Profile of Candida Resistancy to Fluconazole in Male Patient with Oral Candidiasis and HIV/AIDS

Dwi Murtiastutik, Cut Shelma Maharani, R. Rahmadewi
{"title":"Profile of Candida Resistancy to Fluconazole in Male Patient with Oral Candidiasis and HIV/AIDS","authors":"Dwi Murtiastutik, Cut Shelma Maharani, R. Rahmadewi","doi":"10.4172/2155-6113.1000790","DOIUrl":null,"url":null,"abstract":"Background: Oral candidiasis is one of the most common opportunistic infections found in patients with Human Immunodeficiency Virus (HIV)/Acquired immune deficiency syndrome (AIDS). The number of HIV/AIDS patient increases every years. Past studies revelead the increment in the resistance of Candida species causing oral candidiasis against Fluconazole despite Fluconazole being the treatment of choice for this condition. \nObjective: To evaluate the resistancy of Candida species to fluconazole in male patients with oral candidiasis and HIV/AIDS. \nMethods: This was a descriptive observational study conducted in Dr. Soetomo General Hospital, Surabaya. The candida species was identified by using conventional methods. Resistancy against fluconazole were evaluated bydiskdiffusion method. \nResults: There were 20 research subjects with 37 isolates of Candida species growing in culture. Candida species was found in 20 (54.1%) isolates, while 17 (45.9%) isolates showed non-albicans species. The resistance test of Candida species to fluconazole revealed that 18 (48.6%) isolates were resistant to fluconazole. Majority of the resistant isolates were of Candida non-albicans 13 isolates (72.2%). \nConclusion: The use of fluconazole drugs especially in patients with HIV/AIDS should be reevaluated as Candida species has developed high resistance towards the medication.","PeriodicalId":89166,"journal":{"name":"Journal of AIDS & clinical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of AIDS & clinical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2155-6113.1000790","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background: Oral candidiasis is one of the most common opportunistic infections found in patients with Human Immunodeficiency Virus (HIV)/Acquired immune deficiency syndrome (AIDS). The number of HIV/AIDS patient increases every years. Past studies revelead the increment in the resistance of Candida species causing oral candidiasis against Fluconazole despite Fluconazole being the treatment of choice for this condition. Objective: To evaluate the resistancy of Candida species to fluconazole in male patients with oral candidiasis and HIV/AIDS. Methods: This was a descriptive observational study conducted in Dr. Soetomo General Hospital, Surabaya. The candida species was identified by using conventional methods. Resistancy against fluconazole were evaluated bydiskdiffusion method. Results: There were 20 research subjects with 37 isolates of Candida species growing in culture. Candida species was found in 20 (54.1%) isolates, while 17 (45.9%) isolates showed non-albicans species. The resistance test of Candida species to fluconazole revealed that 18 (48.6%) isolates were resistant to fluconazole. Majority of the resistant isolates were of Candida non-albicans 13 isolates (72.2%). Conclusion: The use of fluconazole drugs especially in patients with HIV/AIDS should be reevaluated as Candida species has developed high resistance towards the medication.
男性口腔念珠菌病合并HIV/AIDS患者念珠菌对氟康唑的耐药性分析
背景:口腔念珠菌感染是人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)患者最常见的机会性感染之一。艾滋病毒/艾滋病患者的人数每年都在增加。过去的研究表明,引起口腔念珠菌感染的念珠菌对氟康唑的耐药性增加,尽管氟康唑是治疗这种疾病的首选药物。目的:评价男性口腔念珠菌感染和HIV/AIDS患者念珠菌对氟康唑的耐药性。方法:这是一项在泗水Soetomo综合医院进行的描述性观察性研究。采用常规方法对念珠菌进行了鉴定。用纸片扩散法测定对氟康唑的耐药性。结果:共有20名研究对象,37株念珠菌在培养基中生长。在20个(54.1%)分离株中发现念珠菌,而17个(45.9%)分离株显示非白色念珠菌。念珠菌对氟康唑的耐药性试验表明,18株(48.6%)菌株对氟康唑具有耐药性。大多数耐药菌株为非白色念珠菌13株(72.2%)。结论:应重新评估氟康唑药物的使用,尤其是在HIV/AIDS患者中,因为念珠菌对药物产生了高耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信